Swara Baby Products files for Rs 1,000 Cr IPO; FirstCry parent to sell Rs 300 Cr in OFS

FirstCry-owned Swara Baby Products, India's largest contract manufacturer of disposable hygiene products, filed its DRHP for a Rs 1,000 Cr IPO split between a Rs 500 Cr fresh issue and Rs 500 Cr OFS. Proceeds will fund a new Madhya Pradesh facility and debt repayment. FY26 revenue hit Rs 1,164 Cr, up 23.4% YoY, with Rs 96 Cr profit.

— Source publishedThu, 2 Jul, 2026, 13:11 IST·First seen Thu, 2 Jul, 2026, 13:12 IST·Source Entrackr · Newsletter

What happened

FirstCry-owned Swara Baby Products, India's largest contract manufacturer of disposable hygiene products, filed DRHP for a Rs 1,000 Cr IPO. FirstCry will sell

Key facts

  • Rs 1,000 Cr IPO
  • Rs 500 Cr fresh issue
  • Rs 500 Cr OFS
  • Rs 300 Cr FirstCry OFS
  • 76.59% stake
  • Rs 1,164 Cr FY26 revenue
  • 23.4% YoY growth
  • Rs 96 Cr profit

Why this matters

FirstCry parent selling Rs 300 Cr via OFS while Swara scales as India's largest disposable-hygiene contract manufacturer flags both a partial monetization play and a consolidating supplier landscape worth mapping for M&A or partnership angles.

What to watch

  • SEBI observations / DRHP approval timeline
  • Disclosed share of revenue from FirstCry vs third-party brands (concentration risk)
  • MP facility commissioning timeline and incremental capacity numbers
  • Debt-repayment quantum vs fresh-issue proceeds split
  • Grey market premium and anchor-book quality at pricing
  • Margin trajectory given raw-material (pulp/SAP) input volatility
  • Rival hygiene/FMCG contract manufacturers and diaper brands (Nobel Hygiene, Millennium, P&G/Kimberly-Clark suppliers) reassess capex and pricing to defend share
  • FirstCry/Brainbees investors read the OFS as partial deleveraging and de-risking of the parent's balance sheet
  • Anchor investors probe customer-concentration disclosures and third-party (non-FirstCry) revenue mix
  • Analysts benchmark valuation against listed FMCG-manufacturing and private-label peers rather than D2C baby brands

Also reported by